Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

This article originally appeared here.
Share this content:
Medicaid Expansion Ups Preemptive Listing for Kidney Transplant
Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

THURSDAY, June 21, 2018 (HealthDay News) -- The proportion of new preemptive listings for kidney transplantation with Medicaid coverage increased in states with Medicaid expansion in the post-expansion era, according to a study published online June 21 in the Clinical Journal of the American Society of Nephrology.

Meera N. Harhay, M.D., from the Drexel University College of Medicine in Philadelphia, and colleagues performed a retrospective observational study of adults listed for kidney transplantation using the United Network of Organ Sharing database. Data were included for the pre-Medicaid expansion era (Jan. 1, 2011, to Dec. 31, 2013) and the post-Medicaid expansion era (Jan. 1, 2014, to Dec. 31, 2016).

The researchers observed a 59 percent relative increase in Medicaid-covered preemptive listings from the pre- to post-expansion period in the 24 states that fully implemented Medicaid expansion, compared with an 8.8 percent increase among 19 Medicaid non-expansion states. The adjusted proportion of listings with Medicaid coverage decreased by 0.3 percent (4.0 to 3.7 percent) among non-expansion states compared with a 3.0 percent increase (7 to 10 percent) among expansion states from the pre- to post-expansion period. Medicaid expansion correlated with absolute increases in Medicaid coverage by 1.4, 4.0, 5.9, and 5.3 percent among white, black, Hispanic, and other listings, respectively.

"Medicaid expansion was associated with an increase in the proportion of new preemptive listings for kidney transplantation with Medicaid coverage, with larger increases in Medicaid-coverage among racial and ethnic minority listings than among white listings," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »